Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.51%
- Poor long term growth as Net Sales has grown by an annual rate of 13.02% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.94 times
The company has declared Positive results for the last 5 consecutive quarters
With ROCE of 8.8, it has a Very Expensive valuation with a 28.1 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.32% of the company
Stock DNA
Specialty Chemicals
INR 1,961 Cr (Micro Cap)
361.00
31
0.00%
0.32
8.95%
30.43
Total Returns (Price + Dividend) 
Indokem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Indokem Faces Intense Selling Pressure Amid Consecutive Losses
Indokem Ltd, a key player in the specialty chemicals sector, is experiencing significant selling pressure with only sell orders recorded today. The stock has witnessed a sharp decline, marking a reversal after three consecutive days of gains, signalling distress selling and a lack of buyer interest in the current market environment.
Read More
Indokem’s Market Assessment Revised Amid Strong Returns and Valuation Insights
Indokem, a microcap player in the specialty chemicals sector, has recently undergone a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. This reassessment comes amid notable stock performance and evolving financial indicators, offering investors a nuanced perspective on the company’s current standing.
Read More
Indokem Faces Intense Selling Pressure as Stock Hits Lower Circuit
Indokem Ltd, a key player in the Specialty Chemicals sector, experienced a sharp decline today as the stock hit its lower circuit with only sell orders in the queue, signalling extreme selling pressure and distress among investors.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
31-Jan-2026 | Source : BSEPursuant to Regulation 47 of the SEBI (LODR) Regulations 2015 we enclose herewith copies of the newspaper cutting extracts of Unaudited Financial Results for the Quarter and Nine months ended 31st December 2025 as approved by the Board of Directors of the Company in its meeting held on Friday 30th January 2026.
Results- Financial Results For The Quarter Ended 31St December 2025
30-Jan-2026 | Source : BSEThe unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December 2025 were approved by the Board of Directors at its meeting held today. Results are enclosed with this intimation.
Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 30.01.2026
30-Jan-2026 | Source : BSEPursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that the Board of Directors at its Meeting held today has approved the matter as mentioned in the enclosed intimation.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 10 Schemes (0.1%)
Held by 0 FIIs
Vindhyapriya Holdings Pvt Ltd (19.76%)
Sangeetha S (1.79%)
25.95%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is -3.18% vs 7.80% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -44.59% vs 628.57% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 1.99% vs -5.01% in Sep 2024
Growth in half year ended Sep 2025 is 180.43% vs 72.67% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.18% vs -0.87% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 337.50% vs 87.67% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 8.06% vs 47.33% in Mar 2024
YoY Growth in year ended Mar 2025 is 151.21% vs -2,096.77% in Mar 2024